FDA Approves Tralokinumab for Treating Eczema in Adolescents
The US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate ...
Read moreThe US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate ...
Read more© 2023 earth-news.info